JBIO (Jade Biosciences) Pretax Margin %: % (As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $21.51
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Pretax Margin %?

Jade Biosciences JBIO -1.38% 12 Pretax Margin % is % as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 940 Biotechnology companies, Jade Biosciences ranks worse than 106382.87% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Jade Biosciences's Pre-Tax Income for the three months ended in Mar. 2026 was $-40.35 Mil. Jade Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Jade Biosciences's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Jade Biosciences's Pretax Margin % or its related term are showing as below:


JBIO's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.895
* Ranked among companies with meaningful Pretax Margin % only.

Jade Biosciences  (NAS:JBIO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Jade Biosciences Pretax Margin % Related Terms

Jade Biosciences Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Pretax Margin % Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Pretax Margin %
0.00 0.00

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JBIO vs AVLN, ARDX, IMTX: Pretax Margin % Comparison

For the Biotechnology subindustry, Jade Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jade Biosciences Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jade Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Jade Biosciences's Pretax Margin % falls into.


JBIO
12GF Score
Jade Biosciences Inc JBIO
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Jade Biosciences's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-127.352/0
= %

Jade Biosciences's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-40.352/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Jade Biosciences (JBIO) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Jade Biosciences and its competitors. According to the industry distribution chart, Jade Biosciences ranks #999999 out of 940 companies in the Biotechnology industry.
Is Jade Biosciences' Pretax Margin % too high?
Jade Biosciences' current Pretax Margin % is %. Based on the distribution chart, Jade Biosciences ranks #999999 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Pretax Margin % compare to AVLN and ARDX?
According to the Biotechnology industry distribution chart, Jade Biosciences ranks #999999 out of 940 companies for Pretax Margin %. This places Jade Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Pretax Margin % of %. The current Pretax Margin % is %. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.51
Price